Exosomes as drug delivery vehicles for Parkinson's disease therapy; Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells; Engineering macrophage-derived exosomes for targeted paclitaxel delivery to pulmonary metastases: in vitro and in vivo evaluations; Towards nanomedicines of the future: Remote magneto-mechanical actuation of nanomedicines by alternating magnetic fields; Macrophage delivery of therapeutic nanozymes in a murine model of Parkinson’s disease; Specific transfection of inflamed brain by macrophages: a new therapeutic strategy for neurodegenerative diseases; Macrophage-derived extracellular vesicles as drug delivery systems for triple negative breast cancer (TNBC) therapy; Macrophages with cellular backpacks for targeted drug delivery to the brain; Well-defined cross-linked antioxidant nanozymes for treatment of ischemic brain injury; Bioorganic synthesis in reverse micelles and related systems; Changing the enzyme reaction rate in magnetic nanosuspensions by a non‐heating magnetic field; Macrophages offer a paradigm switch for CNS delivery of therapeutic proteins; Cross-linked antioxidant nanozymes for improved delivery to CNS; Recent advances in the synthesis of Fe3O4@ AU core/shell nanoparticles; TPP1 delivery to lysosomes with extracellular vesicles and their enhanced brain distribution in the animal model of batten disease; Magnetite-Gold nanohybrids as ideal all-in-one platforms for theranostics; A simple and highly effective catalytic nanozyme scavenger for organophosphorus neurotoxins; Theranostic multimodal potential of magnetic nanoparticles actuated by non-heating low frequency magnetic field in the new-generation nanomedicine; pH-dependent substrate preference of pig heart lipoamide dehydrogenase varies with oligomeric state: response to mitochondrial matrix acidification; Blood-borne macrophage–neural cell interactions hitchhike on endosome networks for cell-based nanozyme brain delivery
